- Understanding the role of iron in human health and disease
- Improving the diagnosis of iron disorders
- Developing better medications for common and rare iron disorders
The biennial meeting of the International Bioiron Society was held at the Luskin Center at UCLA, May 7-11, 2017, organized by Elizabeta Nemeth and Tomas Ganz. It was attended by 416 participants from 30 countries, who enjoyed the program and the new conference facilities.
At the annual conference of the Society for Reproductive Investigation, held in San Diego, March 6-10, 2018, our graduate student Allison Fisher presented her studies of the adverse interaction of iron and inflammation in a mouse model of pregnancy. Her poster attracted much attention and elicited spirited discussion by experts in the field.
Silarus Therapeutics is developing therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. Silarus was founded based on intellectual property developed in our center and in-licensed from UCLA. Under a license from UCLA, Intrinsic LifeSciences has developed a "research use only" assay for human erythroferrone sold to many clinical researchers worldwide.